NOAEL Studies
Cosmetic Ingredient
CI 10316 (Ext. D&C Yellow No. 7) NOAEL Studies
INCI: CI 10316
CAS: 846-70-8
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 30 | mg/kg bw/day | rat | oral | 90 day | Subchronic | PAFA; Damme, B.et al. 13-Week Oral (Gavage) ToxicityStudy in the Wistar Rat; RCC |
SCCNFP Opinion 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =0 | mg/kg bw/day | guinea pig | - | 18 month | developmental toxicity | Ref.: 12 Human studies No data 2, p.16 |
| SCCNFP Opinion | NOAEL | =30 | mg/kg bw/day | - | dermal | Sub-chronic | repeated dose toxicity | p.8 |
| SCCNFP Opinion | NOAEL | =50 | mg/kg bw/day | pig | - | developmental | developmental toxicity | p.12 |
SCCS Opinion 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.0009 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.23 |
| SCCS Opinion | NOAEL | =0.0011 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.23 |
| SCCS Opinion | NOAEL | =30 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.17 |
| SCCS Opinion | NOAEL | =30 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.23 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw/day | human | - | developmental | developmental toxicity | p.22 |
Regulatory source 11 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | developmental toxicity | 0 | mg/kg bw/day | guinea pig | - | 18 month | developmental toxicity | p.16 |
| Regulatory source | developmental toxicity | 50 | mg/kg bw/day | pig | - | developmental | developmental toxicity | p.12 |
| Regulatory source | developmental toxicity | 50 | mg/kg bw/day | guinea pig | - | 18 month | developmental toxicity | p.16 |
| Regulatory source | repeated dose toxicity | 30 | mg/kg bw/day | - | dermal | Sub-chronic | repeated dose toxicity | p.8 |
| Regulatory source | dermal absorption | =0.0009 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.23 |
| Regulatory source | dermal absorption | =0.0011 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.23 |
| Regulatory source | dermal absorption | =30 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.23 |
| Regulatory source | developmental toxicity | 30 | mg/kg bw/day | human | - | 90-day | developmental toxicity | p.23 |
| Regulatory source | developmental toxicity | 50 | mg/kg bw/day | human | - | developmental | developmental toxicity | p.22 |
| Regulatory source | developmental toxicity | 50 | mg/kg bw/day | human | - | 90-day | developmental toxicity | p.23 |
| Regulatory source | genotoxicity | 30 | mg/kg bw/day | - | - | Chronic | genotoxicity | p.17 |
openFDA substances 2 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 08F8S9O3I5 | UNII | - | - | - | chemical | - |
| openFDA substances | FDA UNII substance identifier | concept | identifier | - | - | - | concept | - |